These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 26981573)

  • 1. Pattern of endothelial progenitor cells and apoptotic endothelial cell-derived microparticles in chronic heart failure patients with preserved and reduced left ventricular ejection fraction.
    Berezin AE; Kremzer AA; Martovitskaya YV; Berezina TA; Gromenko EA
    EBioMedicine; 2016 Feb; 4():86-94. PubMed ID: 26981573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern of circulating endothelial-derived microparticles among chronic heart failure patients with dysmetabolic comorbidities: The impact of subclinical hypothyroidism.
    Berezin AE; Kremzer AA; Martovitskaya YV; Samura TA; Berezina TA
    Diabetes Metab Syndr; 2016; 10(1):29-36. PubMed ID: 26319410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Content of circulating endothelial progenitor cells in patients with chronic ischemic heart failure with preserved left ventricular ejection fraction].
    Berezin AE; Kremzer AA
    Kardiologiia; 2015; 55(1):14-22. PubMed ID: 26050484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered signature of apoptotic endothelial cell-derived microvesicles predicts chronic heart failure phenotypes.
    Berezin AE; Kremzer AA; Samura TA; Berezina TA
    Biomark Med; 2019 Jun; 13(9):737-750. PubMed ID: 31157550
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship between circulating endothelial progenitor cells and insulin resistance in non-diabetic patients with ischemic chronic heart failure.
    Berezin AE; Kremzer AA
    Diabetes Metab Syndr; 2014; 8(3):138-44. PubMed ID: 25082501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
    Sinning C; Kempf T; Schwarzl M; Lanfermann S; Ojeda F; Schnabel RB; Zengin E; Wild PS; Lackner KJ; Munzel T; Blankenberg S; Wollert KC; Zeller T; Westermann D
    Int J Cardiol; 2017 Jan; 227():272-277. PubMed ID: 27838133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating endothelial-derived apoptotic microparticles and insulin resistance in non-diabetic patients with chronic heart failure.
    Berezin AE; Kremzer AA; Cammarota G; Zulli A; Petrovic D; Martell-Claros N; Sabo J; Kruzliak P
    Clin Chem Lab Med; 2016 Jul; 54(7):1259-67. PubMed ID: 26656612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction.
    Sanders-van Wijk S; van Empel V; Davarzani N; Maeder MT; Handschin R; Pfisterer ME; Brunner-La Rocca HP;
    Eur J Heart Fail; 2015 Oct; 17(10):1006-14. PubMed ID: 26472682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.
    Santhanakrishnan R; Chong JP; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Richards AM; Lam CS
    Eur J Heart Fail; 2012 Dec; 14(12):1338-47. PubMed ID: 22869458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An association of serum vistafin level and number of circulating endothelial progenitor cells in type 2 diabetes mellitus patients.
    Berezin AE; Samura TA; Kremzer AA; Berezina TA; Martovitskaya YV; Gromenko EA
    Diabetes Metab Syndr; 2016; 10(4):205-212. PubMed ID: 27377688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes.
    Zabarovskaja S; Hage C; Linde C; Daubert JC; Donal E; Gabrielsen A; Mellbin L; Lund LH
    Int J Cardiol; 2015; 189():6-11. PubMed ID: 25885866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction.
    Chan MM; Santhanakrishnan R; Chong JP; Chen Z; Tai BC; Liew OW; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong RC; Chai P; Low AF; Richards AM; Lam CS
    Eur J Heart Fail; 2016 Jan; 18(1):81-8. PubMed ID: 26497848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pattern of circulating microparticles in patients with diabetes mellitus with asymptomatic atherosclerosis.
    Berezin AE; Kremzer AA; Berezina TA; Martovitskaya YV
    Acta Clin Belg; 2016 Feb; 71(1):38-45. PubMed ID: 27075791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired immune phenotype of circulating endothelial-derived microparticles in patients with metabolic syndrome and diabetes mellitus.
    Berezin AE; Kremzer AA; Samura TA; Berezina TA; Kruzliak P
    J Endocrinol Invest; 2015 Aug; 38(8):865-74. PubMed ID: 25916429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating microRNAs in heart failure with reduced and preserved left ventricular ejection fraction.
    Wong LL; Armugam A; Sepramaniam S; Karolina DS; Lim KY; Lim JY; Chong JP; Ng JY; Chen YT; Chan MM; Chen Z; Yeo PS; Ng TP; Ling LH; Sim D; Leong KT; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Lam CS; Jeyaseelan K; Richards AM
    Eur J Heart Fail; 2015 Apr; 17(4):393-404. PubMed ID: 25619197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating endothelial progenitor cells as markers for severity of ischemic chronic heart failure.
    Berezin AE; Kremzer AA
    J Card Fail; 2014 Jun; 20(6):438-47. PubMed ID: 24594088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of a Novel Diagnostic Biomarker, the Plasma Cardiac Bridging Integrator 1 Score, With Heart Failure With Preserved Ejection Fraction and Cardiovascular Hospitalization.
    Nikolova AP; Hitzeman TC; Baum R; Caldaruse AM; Agvanian S; Xie Y; Geft DR; Chang DH; Moriguchi JD; Hage A; Azarbal B; Czer LS; Kittleson MM; Patel JK; Wu AHB; Kobashigawa JA; Hamilton M; Hong T; Shaw RM
    JAMA Cardiol; 2018 Dec; 3(12):1206-1210. PubMed ID: 30383171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic significance of serum galectin-3 levels in heart failure with preserved ejection fraction.
    Polat V; Bozcali E; Uygun T; Opan S; Karakaya O
    Acta Cardiol; 2016 Apr; 71(2):191-7. PubMed ID: 27090041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of NT-proBNP in heart failure with preserved versus reduced EF.
    Kang SH; Park JJ; Choi DJ; Yoon CH; Oh IY; Kang SM; Yoo BS; Jeon ES; Kim JJ; Cho MC; Chae SC; Ryu KH; Oh BH;
    Heart; 2015 Dec; 101(23):1881-8. PubMed ID: 26319121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.
    Brouwers FP; de Boer RA; van der Harst P; Voors AA; Gansevoort RT; Bakker SJ; Hillege HL; van Veldhuisen DJ; van Gilst WH
    Eur Heart J; 2013 May; 34(19):1424-31. PubMed ID: 23470495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.